Its approval by regulatory agencies like the FDA for both diabetes management and weight loss is supported by rigorous clinical trials demonstrating its safety and effectiveness when prescribed appropriately
The GLP-1 component of retatrutide drives appetite suppression and slows gastric emptying, contributing to weight loss, while the GIP and glucagon activity influence insulin sensitivity, glucose handling, and energy expenditure
The approval was expedited through the FDAs National Priority Voucher program, a new initiative designed to speed up access to treatments addressing major public health needs
The ozempic 2mg dose for weight loss also produces superior metabolic improvements including better blood sugar regulation and more significant cardiovascular health enhancements for Miami residents
Wegovy Wegovy became available in 2021 and is indicated to treat obesity or patients who are overweight with a weight-related comorbid condition, such as hypertension, type 2 diabetes, or cardiovascular disease